Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Riess

Showing results (91-100 of 313) with videos related to

Pageof 32
Sort By:
The European Journal of Neuroscience|March 18, 2009
Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synucleinFranz Marxreiter, Silke Nuber, Mahesh Kandasamy, et al.
Human Molecular Genetics|January 22, 2020
Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph diseaseJonasz J Weber, Eva Haas, Yacine Maringer, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
Imaging of α-Synuclein Aggregates in a Rat Model of Parkinson's Disease Using Raman MicrospectroscopyFide Sevgi, Eva M Brauchle, Daniel A Carvajal Berrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of primary dystoniasKathrin Grundmann, Ulrike Laubis-Herrmann, Dirk Dressler, et al.
Human Mutation|April 27, 2004
Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patientsAna Djarmati, Katja Hedrich, Marina Svetel, et al.
Molecular and Cellular Neurosciences|June 24, 2008
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347Paola Conforti, Catarina Ramos, Barbara L Apostol, et al.
European Journal of Human Genetics : EJHG|February 11, 2016
Improving the informed consent process in international collaborative rare disease research: effective consent for effective researchSabina Gainotti, Cathy Turner, Simon Woods, et al.
Neuropharmacology|October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HDElisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
Brain : a Journal of Neurology|December 13, 2002
Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's diseaseHirokazu Kobayashi, Rejko Krüger, Katerina Markopoulou, et al.
Molecular Genetics and Metabolism|May 3, 2005
The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysisJochen Reiss, Michael Bonin, Herbert Schwegler, et al.
Pageof 32

Showing results (91-100 of 313) with videos related to

Sort By:
Pageof 32
The European Journal of Neuroscience|March 18, 2009
Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha-synucleinFranz Marxreiter, Silke Nuber, Mahesh Kandasamy, et al.
Human Molecular Genetics|January 22, 2020
Calpain-1 ablation partially rescues disease-associated hallmarks in models of Machado-Joseph diseaseJonasz J Weber, Eva Haas, Yacine Maringer, et al.
Frontiers in Cell and Developmental Biology|September 27, 2021
Imaging of α-Synuclein Aggregates in a Rat Model of Parkinson's Disease Using Raman MicrospectroscopyFide Sevgi, Eva M Brauchle, Daniel A Carvajal Berrio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|September 25, 2004
Lack of mutations in the epsilon-sarcoglycan gene in patients with different subtypes of primary dystoniasKathrin Grundmann, Ulrike Laubis-Herrmann, Dirk Dressler, et al.
Human Mutation|April 27, 2004
Detection of Parkin (PARK2) and DJ1 (PARK7) mutations in early-onset Parkinson disease: Parkin mutation frequency depends on ethnic origin of patientsAna Djarmati, Katja Hedrich, Marina Svetel, et al.
Molecular and Cellular Neurosciences|June 24, 2008
Blood level of brain-derived neurotrophic factor mRNA is progressively reduced in rodent models of Huntington's disease: restoration by the neuroprotective compound CEP-1347Paola Conforti, Catarina Ramos, Barbara L Apostol, et al.
European Journal of Human Genetics : EJHG|February 11, 2016
Improving the informed consent process in international collaborative rare disease research: effective consent for effective researchSabina Gainotti, Cathy Turner, Simon Woods, et al.
Neuropharmacology|October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HDElisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
Brain : a Journal of Neurology|December 13, 2002
Haploinsufficiency at the alpha-synuclein gene underlies phenotypic severity in familial Parkinson's diseaseHirokazu Kobayashi, Rejko Krüger, Katerina Markopoulou, et al.
Molecular Genetics and Metabolism|May 3, 2005
The pathogenesis of molybdenum cofactor deficiency, its delay by maternal clearance, and its expression pattern in microarray analysisJochen Reiss, Michael Bonin, Herbert Schwegler, et al.
Pageof 32